secwatch.observer — SEC 8-K summary
======================================

Issuer:     Harmony Biosciences Holdings, Inc. (HRMY)
CIK:        0001802665
Form:       8-K
Filed at:   2026-05-14T20:31:08+00:00
Accession:  0001104659-26-061237
Event type: other_material
Sentiment:  neutral
Materiality: 0.15
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

Harmony Biosciences shareholders elect four directors, ratify auditor, approve say-on-pay at 2026 annual meeting
--------------------------------------------------------------------------------

- All four Class III director nominees elected: Geno Germano (44.96M for), Troy Ignelzi (32.81M), Ron Philip (31.83M), Andreas Wicki (25.11M).
- Deloitte & Touche ratified as independent auditor for FY2026 with 49.39M for, 0.83M against, 0.17M abstain.
- Say-on-pay advisory vote approved: 33.25M for, 13.04M against, 0.19M abstain; broker non-votes of 3.89M.
- Quorum of 50.38M shares represented out of outstanding; all proposals passed.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1802665/000110465926061237/0001104659-26-061237-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1802665/000110465926061237/hrmy-20260514x8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-26-061237

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer